For the first time, women in the United States have the ability to self-collect a sample to screen for human papillomavirus (HPV).
This week, the U.S. Food and Drug Administration approved two self-swab tests from global medical technology company Becton, Dickinson and Company (BD) and pharmaceutical company Roche Holding AG for “clinical” use, meaning in a private room inside a doctor’s office, mobile clinic or another health care setting.
The tests are not yet available for people to use at home.
HPV is the most common sexually transmitted infection in the U.S. and can lead to several potentially deadly cancers, including cervical cancer.
Advocates hope that by having a less intrusive option, more women, especially those living in underserved areas, can get screened for HPV.
Here’s what you need to know about the infection and the recently approved tests.
What is HPV?
HPV is a very common STI that infects about 13 million …